|
DTL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.88578058618805E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.11630712954047E-12 |
| Normal-vs-Stage2 |
2.681200E-03 |
| Normal-vs-Stage3 |
4.88509999119202E-09 |
| Normal-vs-Stage4 |
1.23180000000112E-06 |
| Stage1-vs-Stage2 |
3.661800E-02 |
| Stage1-vs-Stage3 |
9.015800E-01 |
| Stage1-vs-Stage4 |
9.595400E-01 |
| Stage2-vs-Stage3 |
6.960000E-02 |
| Stage2-vs-Stage4 |
8.445900E-02 |
| Stage3-vs-Stage4 |
9.683800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.10400618938911E-13 |
| Normal-vs-AfricanAmerican |
5.357400E-04 |
| Normal-vs-Asian |
7.31399999454041E-08 |
| Caucasian-vs-AfricanAmerican |
2.240600E-01 |
| Caucasian-vs-Asian |
7.803000E-01 |
| AfricanAmerican-vs-Asian |
2.025800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.52249999777021E-08 |
| Normal-vs-Female |
2.66231481305113E-13 |
| Male-vs-Female |
3.607800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.47437617670221E-13 |
| Normal-vs-Age(41-60Yrs) |
7.4192000321105E-09 |
| Normal-vs-Age(61-80Yrs) |
2.48420000015237E-07 |
| Normal-vs-Age(81-100Yrs) |
1.318550E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.420120E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.059800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.756400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.879600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.657000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.422800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.082400E-01 |
| Classical-VS-Follicular |
3.782500E-02 |
| Classical-VS-Other |
5.824000E-01 |
| Classical-VS-Normal |
3.11972669919669E-14 |
| Tall-VS-Follicular |
1.126330E-02 |
| Tall-VS-Other |
4.652200E-01 |
| Tall-VS-Normal |
2.33180030839719E-10 |
| Follicular-VS-Other |
8.463800E-01 |
| Follicular-VS-Normal |
2.600600E-04 |
| Other-VS-Normal |
2.294800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.28969954108038E-10 |
| Normal-vs-N1 |
1.19500000006489E-07 |
| N0-vs-N1 |
5.238200E-01 |
|
|
